[BRNS] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BRNS] Barinthus Biotherapeutics plc
Announcement Date
30-Dec-2022
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -357.09%
YoY- -40.20%
Quarter Report
BRNS's Result
BRNS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 5,369 6,457 -1 353 147.76%
PBT -18,268 -23,182 -15,139 -10,431 20.53%
Tax -827 -2,019 32 95 -
NP -17,443 -21,189 -15,113 -10,455 18.60%
Tax Rate - - - - -
Total Cost 22,813 27,646 15,112 10,808 28.27%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -324.88 -328.16 1,511,300.00 -2,959.62 -52.11%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.45 -0.56 0.00 0.00 -
EPS Diluted -0.45 -0.56 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.